1. Biomedical application of Chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
   Milad Ashrafizade et al, 2021, Carbohydrate Polymers CrossRef
2. A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets
   Hardeep Singh Tuli et al, 2021, Toxicology in Vitro CrossRef
3. The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update
   Monika Stompor-Gorący, 2021, IJMS CrossRef
4. Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
   Wamidh H Talib et al, 2021, Biomedicines CrossRef
5. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
   Sepideh Mirzaei et al, 2021, Drug Discovery Today CrossRef
6. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
   Sepideh Mirzaei et al, 2021, Cells CrossRef
7. Therapeutic Potential of Emodin for Gastrointestinal Cancers
   Sierra J. McDonald et al, 2022, Integr Cancer Ther CrossRef
8. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals
   Mohan Shankar G. et al, 2022, Front. Pharmacol. CrossRef
9. Combination Anticancer Therapies Using Selected Phytochemicals
   Wamidh H. Talib et al, 2022, Molecules CrossRef
10. Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1
    Xueni Niu et al, 2023, Phytomedicine CrossRef
11. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
    Milad Ashrafizadeh et al, 2023, Environmental Research CrossRef
12. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer
    Wenli Liu et al, 2024, Nutrients CrossRef
13. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer
    Yuan Gao et al, 2024, CCDT CrossRef
14. The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K/AKT/mTOR Pathway
    Yuying Li et al, 2024, IJMS CrossRef
15. Enhancing the Efficacy of Active Pharmaceutical Ingredients in Medicinal Plants through Nanoformulations: A Promising Field
    Yuhao Chen et al, 2024, Nanomaterials CrossRef
16. Medicinal Plants as A Potential Resource for The Discovery of Novel Structures Towards Cancer Drug Resistance Treatment
    Nguyen Minh Hien et al, 2024, Heliyon CrossRef
17. AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer
    Changfeng Li et al, 2025, Sci. Transl. Med. CrossRef